Epigral Limited — Capital/Financing Update 2025

May 5, 2025

==> picture [128 x 18] intentionally omitted <==

05.05.2025

To, National Stock Exchange of India Limited “Exchange Plaza”, Bandra-Kurla Complex, Bandra (East) Mumbai 400 051

BSE Limited Floor- 25, P J Tower, Dalal Street, Mumbai 400 001

SYMBOL:- EPIGRAL

Scrip Code: 543332

Dear Sirs,

Sub.: Statement of Deviation or Variation in utilization of the funds raised through the qualified institutions placement for the quarter ended 31[st] March, 2025

Pursuant to Regulation 32 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with SEBI Master Circular dated 11[th] November, 2024, we hereby confirm that there is no deviation or variation in use of the funds raised through the Qualified Institutional Placement of the Company for the quarter ended 31[st] March, 2025. A Statement confirming that there is no deviation or variation in the use of funds, duly reviewed by the Audit Committee at its meeting held on 5[th] May, 2025, is enclosed herewith as ‘Annexure A’.

We request you to take the same on records. The same is also being uploaded on the Company’s website at www.epigral.com

Thanking You,

Yours faithfully, For Epigral Limited (formerly known as ‘Meghmani Finechem Limited’)

GAURANG Digitally signed by GAURANG GHANSHYAM GHANSHYAM TRIVEDI Date: 2025.05.05 TRIVEDI 21:10:03 +05'30'

Gaurang Trivedi Company Secretary and Compliance Officer M. No. 22307

==> picture [346 x 76] intentionally omitted <==

==> picture [10 x 116] intentionally omitted <==